The European NAFLD Registry
Studying NON RARE IN EUROPE: Non-alcoholic fatty liver disease
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Newcastle University
- Principal Investigator
- Quentin M Anstee, MBBS, PhDNewcastle University
- Enrollment
- 10000 target
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2015 – 2030
Study locations (30)
- Universitair Ziekenhuis Antwerpen, Antwerp, Belgium
- Helsinki University Hospital, Helsinki, Finland
- Le Centre de Recherche Clinique (CRC) du CHU d'Angers, Angers, France
- Institut ICAN - Institute of Cardiometabolism And Nutrition Hôpital de la Pitié Salpêtrière, Paris, France
- UNIVERSITÄTSKLINIKUM der RWTH Aachen, Aachen, Germany
- Charité University Hospital Berlin, Berlin, Germany
- Universitätsklinikum Freiburg, Freiburg im Breisgau, Germany
- UNIVERSITÄTSMEDIZIN der Johannes Gutenberg Universität Mainz, Mainz, Germany
- Universitätsklinikums Würzburg, Würzburg, Germany
- Laiko General Hospital of Athens, Athens, Greece
- Polytechnic University of Marche, Ancona, Italy
- Università degli Studi Milano, Milan, Italy
- Università di Palermo, Palermo, Italy
- Università Cattolica del Sacro Cuore, Rome, Italy
- Department of Medical Sciences University of Torino, Turin, Italy
- +15 more locations on ClinicalTrials.gov
Collaborators
Newcastle-upon-Tyne Hospitals NHS Trust · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Institute of Cardiometabolism and Nutrition, France · University of Cambridge · Örebro University, Sweden · University of Bern · University of Oxford · University of Turin, Italy · University of Angers · University Hospital, Antwerp · Linkoeping University · University of Helsinki · UMC Utrecht · National and Kapodistrian University of Athens · University of Lisbon · University of Milan · University of Palermo · Catholic University of the Sacred Heart · Wuerzburg University Hospital · RWTH Aachen University · University of Nottingham · Medical University of Vienna · University of Birmingham · University of Florence · Assistance Publique - Hôpitaux de Paris · University Medical Center Mainz
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04442334 on ClinicalTrials.govOther trials for NON RARE IN EUROPE: Non-alcoholic fatty liver disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07335198A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and White/European AncestryGlaxoSmithKline
- ACTIVE NOT RECRUITINGNANCT07366710Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PETRigshospitalet, Denmark
- RECRUITINGPHASE4NCT06449833Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLDZhujiang Hospital
- RECRUITINGNANCT06413069Effects of Almonds in Glucose-intolerant Adults (AGAMEMNON)Charite University, Berlin, Germany
- RECRUITINGNANCT06275906Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
- RECRUITINGPHASE1NCT05979389Bicalutamide Therapy in Young Women With NAFLD and PCOSUniversity of California, San Francisco
- RECRUITINGNANCT06704321Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLDValbiotis
- ACTIVE NOT RECRUITINGNANCT06697977Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients with Nonalcoholic Fatty Liver DiseaseUniversity of Jordan
See all trials for NON RARE IN EUROPE: Non-alcoholic fatty liver disease →